<DOC>
	<DOCNO>NCT00859729</DOCNO>
	<brief_summary>This study assess feasibility safety vaccination increase dos xenogenic DNA administer intradermally combination electroporation patient relapse prostate cancer . The DNA encodes prostate specific antigen ( PSA ) Rhesus Macaque ( Macaca mulatta ) , protein 89 % homologous human PSA . The study also assess safety functionality DERMA VAX™ ( Cyto Pulse Sciences ) DNA vaccine delivery system .</brief_summary>
	<brief_title>Dose Finding Study DNA Vaccine Delivered With Intradermal Electroporation Patients With Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male patient . Age &gt; 18 year . HLAA*0201 positive . Histologically confirm prostate cancer . Minimum two ( 2 ) maximum four ( 4 ) year treatment curative salvage radiotherapy . Serum testosterone within normal range . Increasing PSA previous reference value two ( 2 ) consecutive occasion least one month apart minimum 2 ng/mL nadir . PSA double time one ( 1 ) year less . No evidence metastatic prostate cancer . Karnofsky performance status ≥ 80 . Adequate organ function : AST ALT ≤ 2.0 x upper limit normal ( ULN ) ; total serum bilirubin ≤ 1.5 x ULN Calcium ≤ 2.6 mmol/L , serum creatinine ≤ 1.5 x ULN Hb ≥ 100 g/L ; absolute leukocyte count ≥ 3.0 x 109 /L ; platelet ≥100 x 109 /L Life expectancy ≥ 12 month . Swedish English speaking subject . Written informed consent ( subject must capable provide informed consent ) . Previous ablation testis . Radiologic evidence metastatic disease . Prior chemotherapy investigational therapy/agents within 4 week . Active bacterial , viral fungal infection . Carrier HIV , HBV , HCV . Immunosuppressed ( post splenectomy , post stem cell transplantation ) immunosuppressive therapy inhale replacement corticosteroid . Any major illness peripheral blood vein status , investigator 's judgement , substantially increase risk associate sample participation study . Subjects cardiac demand pacemaker . Any reason , opinion investigator , patient participate .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>DNA</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Electroporation</keyword>
	<keyword>xenogenic</keyword>
	<keyword>PSA</keyword>
</DOC>